Key Insights

Highlights

Related Conditions

Often studied with 4 related conditions

Clinical Risk Assessment

Based on trial outcomes

High Risk

Score: 100/100

Termination Rate

100.0%

1 terminated out of 1 trials

Success Rate

0.0%

-86.6% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

0

Data Visualizations

Phase Distribution

Trial Status

Terminated1

Clinical Trials (1)

Showing 1 of 1 trials
Showing all 1 trials

Research Network

Active Sponsors

  • National Cancer Institute (NCI)1

Top Investigators

Related Conditions

  • Esophageal Neoplasms1
  • Endoscopy Gastrointestinal1
  • Cytology1
  • Stomach Neoplasms1

Activity Timeline